These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1839385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A, Mjellem-Jolly N, Hole K.
    Neuropharmacology; 1992 Jan; 31(1):25-32. PubMed ID: 1531864
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB, Miquel MC, Gozlan H, Hamon M.
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A, Mjellem N.
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [Abstract] [Full Text] [Related]

  • 9. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H.
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock.
    Heal DJ, Smith SL.
    Neuropharmacology; 1988 Dec; 27(12):1239-48. PubMed ID: 2977427
    [Abstract] [Full Text] [Related]

  • 12. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M, Kennett GA, Curzon G.
    Eur J Pharmacol; 1990 Mar 20; 178(2):179-87. PubMed ID: 1691712
    [Abstract] [Full Text] [Related]

  • 13. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR, Peroutka SJ.
    Biochem Pharmacol; 1986 Jun 15; 35(12):1943-9. PubMed ID: 3013203
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters.
    Green AR.
    Neuropharmacology; 1987 Jul 15; 26(7B):815-22. PubMed ID: 2889156
    [Abstract] [Full Text] [Related]

  • 19. Effects of repeated electroconvulsive shock on serotonin1A receptor binding and receptor-mediated hypothermia in the rat.
    Stockmeier CA, Wingenfeld P, Gudelsky GA.
    Neuropharmacology; 1992 Nov 15; 31(11):1089-94. PubMed ID: 1475018
    [Abstract] [Full Text] [Related]

  • 20. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 15; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.